In vivo DNA methylation editing in zebrafish

Fang Liang,Zijiong Dong,Jianmin Ye,Wei Hu,Ramji Kumar Bhandari,Kangsen Mai,Xuegeng Wang
DOI: https://doi.org/10.1080/15592294.2023.2192326
2023-03-23
Epigenetics
Abstract:The CRISPR/dCas9-based epigenome editing technique has driven much attention. Fused with a catalytic domain from Dnmt or Tet protein, the CRISPR/dCas9-DnmtCD or -TetCD systems possess the targeted DNA methylation editing ability and have established a series of in vitro and in vivo disease models. However, no publication has been reported on zebrafish ( Danio rerio ), an important animal model in biomedicine. The present study demonstrated that CRISPR/dCas9-Dnmt7 and -Tet2 catalytic domain fusions could site-specifically edit genomic DNA methylation in vivo in zebrafish and may serve as an efficient toolkit for DNA methylation editing in the zebrafish model.
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?